GlassScriptPhysician profile
Mary L Perry
NPI 1770527913
$444.81
in general payments reported to CMS, 2019-2025
10 companies · $39.76 in 2025
The $39.76 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $46.00 · 2021: $12.73 · 2022: $99.96 · 2023: $47.90 · 2024: $50.92 · 2025: $39.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $114.57 | 2019-2025 | Myosure Tissue Removal Device, Aptima |
| Duchesnay USA Incorporated | $78.92 | 2019 | |
| Penumbra, INC. | $77.89 | 2022 | |
| Biogen, INC. | $50.92 | 2024 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $35.80 | 2021-2023 | |
| Organon LLC | $22.07 | 2022 | |
| Allergan, INC. | $20.88 | 2019 | |
| Smith+Nephew, INC. | $17.32 | 2025 | Pico 14, "Acticoat 4"" X 4""" |
| Minerva Surgical, INC | $14.93 | 2019 | |
| Abbvie INC. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.